Previous close | 23.14 |
Open | 22.61 |
Bid | 25.04 x 400 |
Ask | 25.11 x 800 |
Day's range | 22.61 - 25.15 |
52-week range | 22.36 - 50.78 |
Volume | |
Avg. volume | 908,304 |
Market cap | 1.976B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 49.18 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript May 6, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $-0.04221 EPS, expectations were $0.55. IART isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Despite mixed financial results, Integra Lifesciences outlines strategic moves and robust international growth in the first quarter of 2024.